{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T13:15:04Z","timestamp":1661865304922},"reference-count":15,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clinthera.2018.07.022","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:58:33Z","timestamp":1535417913000},"page":"1592-1595","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hydralazine-associated Amenorrhea in a Premenopausal Patient With Chronic Kidney Disease: A Case Report and Review of Literature"],"prefix":"10.1016","volume":"40","author":[{"given":"Kwadwo A.","family":"Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Allspaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram","family":"Al-Makki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Shepler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.07.022_bib0001","unstructured":"Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System. Chronic Kidney Disease (CKD) Surveillance Project website. Available at: https:\/\/nccd.cdc.gov\/ckd\/default.aspx. Accessed September 4, 2017."},{"key":"10.1016\/j.clinthera.2018.07.022_bib0002","unstructured":"Center for Disease Control and Prevention. National Center for Health Statistics. Table 51: End-stage renal disease patients, by selected characteristics: United States, selected years 1980\u20132010. Available at: https:\/\/www.cdc.gov\/nchs\/hus\/contents2011.htm. Accessed September 4, 2017."},{"key":"10.1016\/j.clinthera.2018.07.022_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/snep.2002.28640","article-title":"Pathophysiology of hypertension in renal failure","volume":"22","author":"Salem","year":"2002","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0004","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/hr.2015.67","article-title":"Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease","volume":"38","author":"Kanzaki","year":"2015","journal-title":"Hypertens Res"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0006","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0007","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1681\/ASN.V391575","article-title":"Angiotensin-converting enzyme inhibitor fetopathy","volume":"3","author":"Pryde","year":"1993","journal-title":"J Am Soc of Nephrol"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0008","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/HJH.0b013e32835fdefa","article-title":"Sexual activity and function among middle-aged and older men and women with hypertension","volume":"31","author":"Spatz","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0009","first-page":"929","article-title":"Pharmacological causes of hyperprolactinemia","volume":"3","author":"Torre","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0974-1208.121400","article-title":"Hyperprolactinemia","volume":"6","author":"Majumdar","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0011","year":"2017"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0012","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1210\/jc.2004-1286","article-title":"Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile","volume":"90","author":"Rickenlund","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mvre.2002.2417","article-title":"Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro","volume":"64","author":"Gorny","year":"2002","journal-title":"Microvasc Res"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1751-7176.2011.00573.x","article-title":"Hydralazine-induced lupus erythematosus","volume":"14","author":"Handler","year":"2012","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.clinthera.2018.07.022_bib0015","first-page":"1374","article-title":"Amenorrhea: evaluation and treatment","volume":"73","author":"Master-Hunter","year":"2006","journal-title":"Am Fam Physician"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818303291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818303291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T12:53:46Z","timestamp":1661864026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818303291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0149291818303291"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.07.022","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydralazine-associated Amenorrhea in a Premenopausal Patient With Chronic Kidney Disease: A Case Report and Review of Literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}